Integrin α6-targeted SPECT Imaging of Breast Cancer
NCT04289532
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
COMPLETED
Status
9
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
99mTc-RWY
Sponsor
Peking University
Collaborators
[object Object]
[object Object]